{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:14:52Z","timestamp":1779891292343,"version":"3.53.1"},"reference-count":0,"publisher":"Managed Care and Healthcare Communications, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Manag Care"],"DOI":"10.37765\/ajmc.2023.89444","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T21:18:14Z","timestamp":1697750294000},"page":"e299-e306","source":"Crossref","is-referenced-by-count":4,"title":["Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California"],"prefix":"10.37765","volume":"29","member":"24492","published-online":{"date-parts":[[2023,10,20]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T21:18:16Z","timestamp":1697750296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/real-world-value-of-direct-acting-antivirals-for-hepatitis-c-at-kaiser-permanente-southern-california"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":0,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,1]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2023.89444","archive":["Portico"],"relation":{},"ISSN":["1936-2692","1088-0224"],"issn-type":[{"value":"1936-2692","type":"electronic"},{"value":"1088-0224","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,20]]}}}